ACR Appropriateness Criteria Hodgkin Lymphoma—Unfavorable Clinical Stage I and II

This is a clinical practice guideline for patients with early-stage unfavourable Hodgkin lymphoma. The guideline reviews treatment principles and important clinical trials. Recommendations are provided on chemotherapy and chemoradiotherapy regimens, including a discussion on optimal radiation dose, volume, and techniques. Special topics of interest include the management of refractory Hodgkin Lymphoma.